1.Amplification and Overexpression of Cyclin D1 in Head and Neck Squamous Cell Carcinomas.
Korean Journal of Otolaryngology - Head and Neck Surgery 1997;40(12):1801-1807
BACKGROUND: Overexpression of the cell cycle control gene, cyclin D1 may, at least in some tumor types, provide a prognostic marker. Cyclin D1 is expressed during the G1 phase of the cell cycle and becomes associated with its catalytic partner CDK4 or CDK6. This association may overcome the G1 arrest. OBJECTIVES: To establish the frequency of cyclin D1 protein overexpression and to evaluate its correlation with cyclin D1 gene amplification and its correlation with clinico-pathologic variables that are used in clinical practice. MATERIALS AND METHODS: The cyclin D1 gene amplification was estimated with the differential polymerase chain reaction(PCR) and cyclin D1 protein overexpression was evaluated with immunohistochemical study in 32 cases of resectable head and neck squamous cell carcinoma(SCC). The presence or absence of cyclin D1 protein overexpression was correlated with anatomical sites, T stage, nodal involvement, pathologic grade and survival rate. RESULTS: Six SCC cases(18.7%) showed the amplification of cyclin D1 gene. A highly statistical correlation between cyclin D1 gene amplification and cyclin D1 protein overexpression was noted(p<0.05). However in seven cases(21.9%) there was cyclin D1 protein overexpression without gene amplification. There was no correlation between cyclin D1 protein overexpression and known clinicopathologic variables(T and N stages, pathologic grade)(p>0.05). But overexpression of cyclin D1 protein was associated with a poor survival of these cases(p<0.05). CONCLUSIONS: Overexpression of cyclin D1 is the independent prognostic factor for the head and neck squamous cell carcinoma. The cyclin D1 gene amplification results in the overexpression of cyclin D1 protein. But additional genetic mechanisms are involved in the protein overexpression. Therefore, cyclin D1 oncogene may be important in tumorigenesis in the head and neck squamous cell carcinoma.
Carcinogenesis
;
Carcinoma, Squamous Cell*
;
Cell Cycle
;
Cell Cycle Checkpoints
;
Cyclin D1*
;
Cyclins*
;
G1 Phase
;
Gene Amplification
;
Genes, bcl-1
;
Head*
;
Neck*
;
Oncogenes
;
Survival Rate
2.Expression of TGF-β, PDGF, Type I and II Collagen, and Osteonectin During Fracture Healing in Rat
Chi Hong KIM ; Bum Woo YEOM ; Han Kyeom KIM ; Jung Suk MOON ; Hye Rim PARK
The Journal of the Korean Orthopaedic Association 1996;31(5):1205-1217
To define the basic sequential events of the healing process in normal fracture and evaluate the role of growth regulatory molecules and extracellular matrix components, the expression of transforming growth factor β(TGF-β), platelet-derived growth factor(PDGF), type I and II collagen, and chemistry during the healing process of an experimental fracture of tibia in 41 adult rats for 7 weeks using ABC methods. The phases of inflammation, reparation, and remodeling followed each other in sequence. The inflammatory phase was characterized by hemorrhage, edema, and infiltration of inflammatory cells on the first day. During the reparative phase, the undifferentiated mesenchyme undergoes rapid chondrogenesis, followed by endochondral ossification and supplemented by appositional bone formation. At day 3, the expression of TGF-β and PDGF was noted in the undifferentiated mesenchymal cells and from day 5, these two growth factors were detected in the osteoblasts and extracellular matrix in areas of endochondral ossification and newly formed periosteal bone. From day 3, the expression of type I collagen and osteonectin was noted in the osteoblasts and extracellular matrix in both endochondral ossification and appositional bone growth as a marker of ossification. From day 3, type III collagen was mainly expressed in the plump mesenchymal cells showing chondroid differentiation and chondroid matrix as a marker of cartilaginous reparative phase. From day 14, these growth factors and extracellular matrix components were decreased in staining intensity and at the 5th week, the histology and immunostaining pattern were similar to the mature bone.
Adult
;
Animals
;
Bone Development
;
Chemistry
;
Chondrogenesis
;
Collagen Type I
;
Collagen Type III
;
Collagen
;
Edema
;
Extracellular Matrix
;
Fracture Healing
;
Hemorrhage
;
Humans
;
Inflammation
;
Intercellular Signaling Peptides and Proteins
;
Mesoderm
;
Osteoblasts
;
Osteogenesis
;
Osteonectin
;
Rats
;
Tibia
;
Transforming Growth Factors
3.Mast Cells in 10-Dimethyl-1,2 Benzanthracene (DMBA)-Induced Rat Mammary Carcinomas: Relationship with Matrix Metallproteinase (MMP)-2 and MMP-9 Expression.
Hyun Ho LEE ; Ae Ree KIM ; Bum Woo YEOM ; Insun KIM
Korean Journal of Pathology 2001;35(4):306-313
BACKGROUND: It has been suggested that mast cells are involved in the tumor growth and progression by production of a variety of enzymes and growth factors. They were studied in the 10-dimethyl-1,2 benzanthracene (DMBA)-induced rat mammary tumors, and evaluated in relation with the production of tryptase, chymase, and matrix metalloproteinase (MMP)-2 and MMP-9. METHODS: Preneoplastic and neoplastic breast tissues of Sprague-Dawley female rats were obtained every week after DMBA treatment for 12 weeks. Toluidine blue stain was used for the identification of mast cells. Mast cell tryptase was studied by immunohistochemistry, and chymase by esterase stain. MMP-2 and MMP-9 were measured by Western blotting. RESULTS: The numbers of mast cells in breast cancers were higher than in preneoplastic tissues, and there was a positive correlation between the numbers of tryptase-positive cells and the tumor size. MMP-9 quantity was correlated with the numbers of toluidine blue and chymase positive cells, but not with tryptase-positive cells and tumor size. Both active and inactive forms of MMP-2 and MMP-9 were identified in zymogram. CONCLUSIONS: The mast cells are increased in the DMBA-induced breast cancers, and their tryptase and chymase may play a role in tumor progression with or without participation of MMP-2 and MMP-9.
9,10-Dimethyl-1,2-benzanthracene
;
Animals
;
Blotting, Western
;
Breast
;
Chymases
;
Female
;
Humans
;
Immunohistochemistry
;
Intercellular Signaling Peptides and Proteins
;
Mast Cells*
;
Rats*
;
Rats, Sprague-Dawley
;
Tolonium Chloride
;
Tryptases
4.DNA Ploidy Study in 1,673 Fresh Solid Tumors.
Min Joo KIM ; Han Kyeum KIM ; Yang Seok CHAE ; Bum Woo YEOM ; In Sun KIM
Journal of the Korean Cancer Association 1998;30(6):1279-1293
PURPOSE: To evaluate the possible role of DNA content abnomrality in solid tumors as a diagnostic indicator in Korean patients, the incidence of aneuploidy in the major organs were analyzed and compared with the incidences which have been reported in the literatures. MATERIALS AND METHODS: Flow cytometric analysis of DNA content were performed on the 1673 fresh tissues of neoplastic lesions which were obtained for the last five years in Hospital. RESULTS: The frequency of aneuploidy was more than 50% in the primary malignant tumors of the stomach, colon, esophagus, liver, biliary tract, pancreas, head and neck organs, salivary gland, lung, breast, ovary, CNS and urinary tract. However, the frequency of aneuploidy was as low as 7% in papillary carcinoma of thyroid and about 30% in renal cell carcinoma and malignant lymphomas. High frequency of aneuploidy (more than 70%) was seen in the metastatic tumors in liver, brain, ovary and lymph nodes. Aneuploidy was also found in benign tumors of salivary gland, adenomas of endocrine organs, meningiomas, smooth muscle tumors and schwannomas. CONCLUSION: The results of present study were in concordant with those of the other domestic and foreign studies. Although aneuploidy can be observed in some benign tumors, DNA ploidy pattern is considered to be an important diagnostic and prognostic factors in malignant lesions of the various organs.
Adenoma
;
Aneuploidy
;
Biliary Tract
;
Brain
;
Breast
;
Carcinoma, Papillary
;
Carcinoma, Renal Cell
;
Colon
;
Diploidy
;
DNA*
;
Esophagus
;
Female
;
Head
;
Humans
;
Incidence
;
Liver
;
Lung
;
Lymph Nodes
;
Lymphoma
;
Meningioma
;
Neck
;
Neurilemmoma
;
Ovary
;
Pancreas
;
Ploidies*
;
Salivary Glands
;
Smooth Muscle Tumor
;
Stomach
;
Thyroid Gland
;
Urinary Tract
5.Expression of Osteopontin and Clusterin in Transitional Cell Carcinoma of the Bladder: Comparison to the Pathologic Stage.
Jong Hyun YOON ; Ju Han LEE ; Bum Woo YEOM ; Nam Hee WON ; Duck Ki YOON
Korean Journal of Urology 2005;46(4):341-346
PURPOSE: This study was performed to evaluate the expressions of osteopontin (OPN) and clusterin in a transitional cell carcinoma (TCC) of the urinary bladder, and then compare their expression rates with the tumor invasiveness. MATERIALS AND METHODS: Twenty-five superficial and 25 invasive TCC were used for immunohistochemical staining. RESULTS: All 25 non-invasive TCC showed a strong positive reaction for OPN. Twenty of the invasive TCC showed a strong positive reaction for OPN, but 5 showed only a weak positive reaction. OPN expression was significantly decreased in the invasive TCC (p=0.02). Eighteen superficial TCC showed a weak positive reaction for clusterin, with 7 showing a negative reaction. Nine invasive TCC showed a strong positive reaction for clusterin, and 11 showed only a weak positive reaction. Five invasive TCC showed a negative reaction for clusterin. Clusterin expression was significantly increased in the invasive TCC (p=0.001). CONCLUSIONS: These results may suggest that OPN and clusterin could be used as markers to predict the biological behavior of a TCC.
Carcinoma, Transitional Cell*
;
Clusterin*
;
Osteopontin*
;
Urinary Bladder*
6.Uterine Tumor Resembling Ovarian Sex-Cord Tumor: A Case Report of the Cytologic Finding.
Insun KIM ; Eun Mee HAN ; Woon Yong JUNG ; Ju Han LEE ; Bum Woo YEOM
Korean Journal of Cytopathology 2003;14(2):71-75
Uterine stromal tumors with features of ovarian sex-cord differentiation are relatively rare. The neoplasms composed of sex cord-like components in more than 50% of the tumor are classified as group II. We report the cytologic findings of a case of uterine tumor resembling ovarian sex-cord tumor. The cervical smears of a 62-year-old woman with submucosal tumor showed loose aggregates of spindle cells as well as glandular or tubular structures of round cells with a distinct cell membrane and a prominent small nucleolus. Because uterine stromal tumor can have sex cord differentiation, its possibility should be considered in the interpretation of cervical smears.
Cell Membrane
;
Female
;
Humans
;
Middle Aged
;
Uterus
;
Vaginal Smears
7.Peutz-Jeghers Syndrome with Multiple Genital Tract Tumors and Breast Cancer: A Case Report with a Review of Literatures.
Seung Hun SONG ; Jae Kwan LEE ; Ho Suk SAW ; Sang Yong CHOI ; Bum Hwan KOO ; Aeree KIM ; Bum Woo YEOM ; Insun KIM
Journal of Korean Medical Science 2006;21(4):752-757
We report here on the multiple genital tract neoplasms in a 41-yr-old Korean woman with Peutz-Jeghers Syndrome (PJS). The patient presented with lower abdominal pain. Her previous medical history was PJS and breast cancer. Pelvic ultrasound showed a multilocular cyst at the right adnexal region, diagnosed as bilateral ovarian mucinous borderline tumors. An ovarian sex cord tumor with annular tubules was incidentally diagnosed together with a minimal deviation adenocarcinoma of the uterine cervix and mucinous metaplasia of both the Fallopian tubal mucosa and the endometrium. Although the cases of multiple genital tract tumors with PJS has rarely been reported, the present case appears to be the first in Korea in which the PJS syndrome was complicated by multiple genital tract tumors and infiltrating carcinoma of the breast. The clinical significance of the multiple genital tract tumors and breast cancer associated with PJS is reviewed.
Uterine Cervical Neoplasms/complications/*pathology
;
Sex Cord-Gonadal Stromal Tumors/complications/pathology
;
Peutz-Jeghers Syndrome/complications/*pathology
;
Ovarian Neoplasms/complications/*pathology
;
Metaplasia
;
Korea
;
Humans
;
Female
;
Fallopian Tubes/pathology
;
Endometrium/pathology
;
Carcinoma, Ductal, Breast/complications/pathology
;
Breast Neoplasms/complications/*pathology
;
Adult
;
Adenocarcinoma/complications/pathology
8.Primary Spinal Oncocytic Paraganglioma.
Ji Hye LEE ; Seong Hwan PARK ; Duk Hyun CHO ; Bum Woo YEOM ; Jong Sang CHOI ; Chul Hwan KIM ; Yeon Lim SUH
Korean Journal of Pathology 2001;35(6):561-564
Paraganglioma is a generic term applied to tumors of paraganglia, regardless of location, and composed largely of paraganglionic chief cells. It is a rare tumor, especially in the spinal region. When it appears in the craniospinal axis, it is restricted to the cauda equina or filum terminale, and less commonly, the spinal nerve root. We report a case of oncocytic paraganglioma in the spinal nerve root of 13-year-old girl. The tumor was located in intradural and extramedullary areas from the 12th thoracic to the 1st lumbar vertebra. Histologically, the tumor cells with abundant eosinophilic cytoplasms show diffuse compact clusters, which are surrounded by fibers in a reticulin stain, like a nested pattern. The nuclei are round to ovoid in shape with mild atypia. Immunohistochemically, the tumor cells are positive for synaptophysin, neuron-specific enolase and vimentin but are negative for cytokeratin, chromogranin and glial fibrillary acidic protein. Some cells are positive for S-100 protein. The MIB-1 labeling index is low. Ultrastructurally, dense core neurosecretory granules are not found but mitochondrias are commonly noted.
Adolescent
;
Axis, Cervical Vertebra
;
Cauda Equina
;
Cytoplasm
;
Eosinophils
;
Female
;
Glial Fibrillary Acidic Protein
;
Humans
;
Keratins
;
Mitochondria
;
Paraganglioma*
;
Phosphopyruvate Hydratase
;
Reticulin
;
S100 Proteins
;
Spinal Canal
;
Spinal Nerve Roots
;
Spine
;
Synaptophysin
;
Vimentin
9.Genetic and Epigenetic Alterations of the Wnt/beta-catenin Signaling Pathway in Cancer of the Ampulla of Vater.
Gwang Il KIM ; Jeong Boon KIM ; Sang Bum PARK ; Young Sik KIM ; Han Kyeom KIM ; Bom Woo YEOM ; Yang Seok CHAE
Korean Journal of Pathology 2007;41(4):224-231
BACKGROUND: Carcinoma of the ampulla of Vater is rare and its pathogenesis is unclear. The role of epigenetic changes in the APC or CDH1, in the Wnt pathway, has not been reported in ampullary carcinomas. METHODS: We performed immunohistochemistry on 73 sporadic ampullary carcinomas to identify Wnt-related molecules (APC, beta-catenin, E-cadherin, c-erbB2, cyclin D1) and examined mutations in the CTNNB1, loss of heterozygosity of 5q21, and the methylation status of the CpG island of APC and CDH1. RESULTS: Thirteen tumors (17.8%) showed abnormal nuclear localization of beta-catenin; this was more prominent in the intestinal type than in the pancreaticobiliary type (p=0.01). The loss of APC correlated with the loss of beta-catenin or c-erb B2 (p<0.01). The prognosis was worse in the group with APC loss than when APC was maintained (p<0.05). There was no mutation identified in CTNNB1. Six (24%) out of 25 informative cases had 5q21 allelic loss. CpG island methylation in APC and CDH1 was detected in 33 (45.2%) and 29 (31.5%) cases, respectively. CONCLUSIONS: The absence of mutations in CTNNB1 and the epigenetic alteration of APC and CDH1, might be characteristic changes in the Wnt/beta-catenin signaling pathway during the carcinogenesis of ampullary carcinomas.
Ampulla of Vater*
;
beta Catenin
;
Cadherins
;
Carcinogenesis
;
CpG Islands
;
Cyclins
;
Epigenomics*
;
Immunohistochemistry
;
Loss of Heterozygosity
;
Methylation
;
Prognosis
;
Wnt Signaling Pathway
10.A comparison of the Glidescope(R) to the McGrath(R) videolaryngoscope in patients.
Woo Jae JEON ; Kyoung Hun KIM ; Jong Hoon YEOM ; Mi Rang BANG ; Jin Bum HONG ; Sang Yun CHO
Korean Journal of Anesthesiology 2011;61(1):19-23
BACKGROUND: The Glidescope(R) videolaryngoscope is a new device for tracheal intubation that provides an improved view of the larynx. This study was performed to compare the Glidescope with the McGrath videolaryngoscope in terms of time to intubation (TTI) and number of attempts. METHODS: Patients were randomly allocated to one of two groups, Glidescope or McGrath group, by using computer-generated numbers. Tracheal intubation was attempted by an anesthesiologist with extensive experience using these two devices. The operator recorded ease of visualization of glottic structures based on the classification described by Cormack and Lehane. Number of failures, number of attempts and their duration, total intubation time, and events during the whole procedure were recorded. The duration of one attempt was defined as the time elapsed between picking up the endotracheal tube and verification of tracheal intubation with visualization of three expiratory carbon dioxide waveforms. TTI was defined as the sum of the duration of all intubation attempts (as many as three), excluding preoxygenation procedures. RESULTS: TTI was significantly shorter for the Glidescope(R) compared to the McGrath(R) laryngoscope (40.5 vs. 53.3 s, respectively, P < 0.05). However, glottic views obtained at intubation were similar between the two groups. Number of intubation attempts was not significantly different between the two groups (1.03 +/- 0.19 vs 1.10 +/- 0.32, respectively) (mean +/- SD). CONCLUSIONS: Study results demonstrated that the Glidescope reduced total intubation time in comparison with the McGrath, in terms of TTI in patients with normal airways.
Carbon Dioxide
;
Humans
;
Intubation
;
Laryngoscopes
;
Larynx